Home › Atrial Fibrillation › Alabama › Mobile
Atrial Fibrillation clinical trials in Mobile, AL
5 studies for Atrial Fibrillation are looking for participants at sites in and around Mobile (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
RecruitingPhase 2
- Eastern Shore Research Institute, Fairhope · 14 mi away
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
RecruitingObservational study
- Cardiology Associates of Mobile, Mobile
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
RecruitingPhase 3
- Anthos Investigative Site 1041, Mobile
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- University of South Alabama University Hospital, Mobile
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RecruitingObservational study
- Mobile Cardiology Associates, Mobile
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Boston, MA17 studies
- Cleveland, OH17 studies
- Atlanta, GA16 studies
- Philadelphia, PA12 studies
- Jonesboro, AR12 studies
- Chicago, IL12 studies
- Ann Arbor, MI11 studies
- Pittsburgh, PA10 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Austin, TX9 studies
Other studies in Mobile
- Non-Small Cell Lung Cancer13 studies
- Heart Failure13 studies
- Lung Cancer7 studies
- Breast Cancer7 studies
- Ovarian Cancer7 studies
- Obesity7 studies
- Cancer (all types)6 studies
- Melanoma6 studies
- Small Cell Lung Cancer6 studies
- Cardiovascular Disease6 studies
- Overweight5 studies
- Type 2 Diabetes5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.